敗血症診断薬市場規模、シェア、成長分析：技術別、用途別、製品別、方法別、病原体タイプ別、検査タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

敗血症診断薬市場規模は2023年に6億9,000万米ドルと評価され、2024年の7億5,000万米ドルから2032年には14億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.7％で成長する見通しです。

敗血症診断薬市場は、高齢者や免疫不全者などのハイリスク集団における感染症関連の入院件数の増加によって、ヘルスケア分野の重要なセグメントとなっています。マルチプレックスアッセイや迅速PCR検査などの技術的進歩が検出速度と精度を向上させる一方、規制当局の取り組みが敗血症管理方法の改善を促進しています。このような成長の可能性にもかかわらず、非特異的な症状による敗血症診断の複雑さに加え、診断検査費用の高騰といった課題が、資源に制約のある環境での利用を制限しています。さらに、多様な検査プロトコールと標準化の必要性が、革新的技術の採用を妨げる可能性があります。しかし、新たなバイオマーカーの開発、迅速な検査ソリューション、AIと機械学習の統合、共同研究開発の取り組みには機会が存在します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

敗血症診断薬市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 血液培養技術

敗血症診断薬市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 診断センター

敗血症診断薬市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 血液培養培地
• アッセイおよび試薬キット
• 機器
• ソフトウェア

敗血症診断薬市場規模：方法別& CAGR（2025-2032）

• 市場概要
• 従来の診断
• 自動診断

敗血症診断薬市場規模：病原体タイプ別& CAGR（2025-2032）

• 市場概要
• 細菌性敗血症
  • グラム陰性細菌性敗血症
  • グラム陽性細菌性敗血症真菌性敗血症
• その他の病原体タイプ

敗血症診断薬市場規模：検査タイプ別& CAGR（2025-2032）

• 市場概要
• 臨床検査
• ポイントオブケア検査

敗血症診断薬市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院と専門クリニック
• 病理学および基準研究室
• 調査室
• 学術機関

敗血症診断薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• BioMerieux SA（France）
• Becton, Dickinson and Company（BD）（USA）
• Thermo Fisher Scientific, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（Beckman Coulter, Inc.）（USA）
• Bruker Corporation（USA）
• Abbott Laboratories, Inc.（USA）
• Cepheid（USA）
• Luminex Corporation（USA）
• T2 Biosystems, Inc.（USA）
• Siemens Healthineers（Germany）
• Qiagen N.V.（Netherlands）
• Immunexpress, Inc.（USA）
• Seegene Inc.（South Korea）
• Koninklijke Philips N.V.（Netherlands）
• GenMark Diagnostics（USA）
• Wolters Kluwer NV.（Netherlands）
• Epic Systems Corporation.（USA）
• McKesson Corporation.（USA）

結論と提言

Sepsis Diagnostics Market size was valued at USD 0.69 billion in 2023 and is poised to grow from USD 0.75 billion in 2024 to USD 1.46 billion by 2032, growing at a CAGR of 8.7% during the forecast period (2025-2032).

The sepsis diagnostics market is a crucial segment of the healthcare sector, driven by rising infection-related hospitalizations among high-risk populations, including the elderly and immunocompromised individuals. Technological advancements such as multiplex assays and rapid PCR tests are enhancing detection speed and accuracy, while regulatory initiatives are fostering improved sepsis management practices. Despite this growth potential, challenges such as high diagnostic test costs limit accessibility in resource-constrained settings, alongside the complexity of sepsis diagnosis due to its non-specific symptoms. Additionally, varying testing protocols and the need for standardization may hinder the adoption of innovative technologies. However, opportunities exist in the development of new biomarkers, rapid testing solutions, and the integration of AI and machine learning, along with collaborative research and development efforts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sepsis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sepsis Diagnostics Market Segments Analysis

Global Sepsis Diagnostics Market is segmented by Technology, Application, Product, Method, Pathogen Type, Test Type, End Users and region. Based on Technology, the market is segmented into Blood Culture Technology. Based on Application, the market is segmented into Hospitals and Diagnostics Centres. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments and Software. Based on Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Based on Pathogen Type, the market is segmented into Bacterial Sepsis and Other Pathogen Types. Based on Test Type, the market is segmented into Laboratory Tests and Point-Of-Care Tests. Based on End Users, the market is segmented into Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is significantly driven by the rising awareness and training initiatives aimed at healthcare professionals, emphasizing the importance of early sepsis detection and management. This growing focus is leading to a higher uptake of diagnostic tests and related services. Additionally, there has been a surge in public education campaigns highlighting the symptoms and signs of sepsis, which encourages individuals to seek timely medical attention. As a result, this proactive approach not only fosters prompt diagnosis but also enhances testing frequencies, further stimulating the overall growth of the Sepsis Diagnostics market.

Restraints in the Sepsis Diagnostics Market

The Sepsis Diagnostics market faces significant challenges due to the diverse and non-specific signs and symptoms associated with sepsis, which complicate early diagnosis. This complexity can lead to delays in treatment or misdiagnosis, undermining the effectiveness of diagnostic tools. Furthermore, accurate sepsis diagnosis often requires a combination of tests, which adds to the complexity and extends the turnaround time for results. This protracted process can hamper patient outcomes and diminish the perceived value of diagnostic solutions, ultimately restraining the growth and development of the Sepsis Diagnostics market. Addressing these issues is crucial for improving diagnostic efficiency and market expansion.

Market Trends of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is witnessing a significant trend towards the adoption of advanced molecular diagnostic techniques, particularly next-generation sequencing (NGS) and polymerase chain reaction (PCR). These methodologies are revolutionizing pathogen detection by providing accurate and rapid results, drastically reducing the time for diagnosis compared to traditional culture methods. This shift is critical in sepsis management, as early intervention greatly enhances patient outcomes. As healthcare providers increasingly prioritize timely diagnostics, the demand for these innovative technologies is surging, positioning them as essential components in combating sepsis and driving overall market growth. The focus on precision medicine further amplifies this trend, promising enhanced efficacy in treatment protocols.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Sepsis Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Blood Culture Technology

Global Sepsis Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostics Centres

Global Sepsis Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Blood Culture Media
• Assays and Reagent Kits
• Instruments
• Software

Global Sepsis Diagnostics Market Size by Method & CAGR (2025-2032)

• Market Overview
• Conventional Diagnostics
• Automated Diagnostics

Global Sepsis Diagnostics Market Size by Pathogen Type & CAGR (2025-2032)

• Market Overview
• Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis Fungal Sepsis
• Other Pathogen Types

Global Sepsis Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Laboratory Tests
• Point-Of-Care Tests

Global Sepsis Diagnostics Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals And Speciality Clinics
• Pathology and Reference Laboratories
• Research Laboratories
• Academic Institute

Global Sepsis Diagnostics Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • US
  • Canada
• Europe (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Beckman Coulter, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immunexpress, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wolters Kluwer NV. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations